Overview

Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For 25 years, TCT has been the center of new cutting-edge educational content. TCT showcases the latest advances in current therapies and clinical research and our long-standing commitment to life-saving innovation to translate into improved patient care.

CME Accreditation and Designation

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Target Audience

This symposium is designed for interventional cardiologists, radiologists, clinical cardiologists, basic scientists, vascular medicine specialists, cardiac and vascular surgeons, nurses practitioners, cath lab technicians, and other health care professionals with a special interest in the field of interventional and vascular medicine.

Needs Statement

TCT provides the latest evidence-based data presented by leading physicians, nurses and scientists that will affect the practice of interventional cardiology and endovascular medicine, current and emerging techniques and technologies with practical applications, and unparalleled diversity of live-case presentations from universities and medical centers around the world. In the field of interventional cardiology, only TCT combines late breaking science and practical learning that physicians need to improve patient outcomes.

Activity Goals

The overall goal of this activity is to improve competence and performance of our target audience by delivering new cutting-edge educational content that showcases the latest advances in current therapies and clinical research. We hope that our long-standing commitment to life-saving innovation will translate into improved patient care.

Learning Objectives

By the end of the symposium, participants should be able to:

• Apply the results from important clinical trials and evidence-based medicine to guide management of patients with atherosclerosis and structural heart disease
• Incorporate new interventional technologies and procedures into the care of patients with complex coronary and endovascular disease
• Integrate advances in diagnostic evaluation and therapeutics to patients with carotid and peripheral arterial disease
• Implement appropriate pharmacologic management in the care of patients undergoing diagnostic arteriography and interventional therapies before, during, and after catheterization
• Identify new interventional technologies and propose appropriate applications for patients with cardiovascular disease

Disclosure Statement

It is the policy of the Cardiovascular Research Foundation and the American College of Cardiology Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage and/or off-label product use during live cases is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.

Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation and the American College of Cardiology Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.

CME Credit Claim

Successful completion requires a brief evaluation for each of the session attended as well as an evaluation for the TCT conference as a whole. Evaluations will address content, presentation, possible bias, and future educational needs.

For any CME or CNE related inquiry, please contact This email address is being protected from spambots. You need JavaScript enabled to view it. .

Program Sponsorship

This symposium is sponsored by the Cardiovascular Research Foundation.

Program Support

This symposium is partially funded through educational grants from commercial supporters. The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience.

To support this endeavor, the directors and co-directors of TCT create organizational and scientific committees to assist in educational content development and content oversight for live cases, concurrent sessions, case reviews, abstract sessions, practical workshops, and scientific symposia.These sessions are developed without influence from commercial supporters.